TrialTrials2017

Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial.

Carsten-Henning Ohlmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.